Form 4 for WGS GeneDx Holdings Corp.
Accepted 2024-03-12 00:00:00 ET · period of report 2024-03-09 · accession 0001415889-24-007681 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-12 | 2024-03-09 | WGS | Saad Kareem | Chief TRANSFORMATION Off | M - OptEx | $0.00 | +2,841 | 27.3K | +12% | $0 |
| D | 2024-03-12 | 2024-03-09 | WGS | Saad Kareem | Chief TRANSFORMATION Off | M - OptEx | $0.00 | -2,841 | 31.2K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-03-09 | M | A | 2,841 | $0.00 | 27,308 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. |
| 2 | Derivative | Restricted Stock Unit | 2024-03-09 | M | D | 2,841 | $0.00 | 31,249 | D | — · — to — | 2,841 Class A Common Stock | (F1) Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F2) 6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. |